Zydus Lifesciences Set To Weigh Fresh Buyback Plan At May 19 Board Meet

Jyoti Rathi May 13, 2026 320 Views

Zydus Lifesciences has scheduled a key board meeting on May 19, 2026 to review a fresh equity share buyback proposal, alongside its Q4 and full year FY26 results. The move signals the pharma major’s continued focus on capital return and balance sheet optimisation, and will be closely tracked by institutional and retail investors.